Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Nephron Sterile Compounding Center LLC
EIR
•Nephron Sterile Compounding Center LLC•April 21, 2017

Nephron Sterile Compounding Center LLC – FDA EIR, Apr 21, 2017

Record Details

An FDA inspection of Nephron Pharmaceuticals Corporation (also known as Nephron Outsourcing Facility), located in West Columbia, SC, was conducted from April 17 to April 21, 2017. This high-priority inspection focused on assessing the firm's adherence to minimum standards for producing compounded sterile products, evaluating compliance with Section 503B requirements, and ensuring patient safety under the FD&C Act and 21 CFR 211 Good Manufacturing Practices. The inspection revealed several significant deficiencies documented on an FDA Form-483. Key issues included the lack of aseptic process validation for phenylephrine hydrochloride production, inadequate training for visual inspection personnel (using vials instead of syringes, and absence of a defect library), and failure to implement required Supplier Quality Agreements with certain critical suppliers. Additionally, some product labels were missing the firm's address and/or phone number. Verbal discussions with management also highlighted the need for labeling consistency, improved endotoxin reporting, inclusion of formula worksheets in batch records, and larger sample sizes for endotoxin testing. Management acknowledged the observations and indicated that many deficiencies were already being addressed or would be corrected within 15 business days of receiving the FDA Form-483. The company committed to providing documentation of these corrective actions. This inspection aimed to mitigate risks associated with compounded sterile drug production and reinforce regulatory compliance.

Company
Nephron Sterile Compounding Center LLC
Inspection date
April 21, 2017
Product type
drugs
Office
Office of Unapproved Drugs & Labeling Compliance
People
  • Rachael L. Cook (Investigator)
  • Bonita S. Chester (Director of Inspection Readiness)
  • Diane P. Goyette (Senior Advisor)
View Company Profile

ID · 41bfb2b6-fd92-4d0b-afa2-8395e8d3e567

Violation Codes6
21 CFR 211.113(b)21 CFR 211.160(b)21 CFR 211FD&C Act 503B(a)(10)21 CFR 820.5021 CFR 211.22(d)

Full citation text and observation details available on the Dashboard.

Other documents for Nephron Sterile Compounding Center LLC
  • 483 - 2024-09-25September 25, 2024
  • 483 - 2023-02-10February 10, 2023
  • 483 - 2022-04-20April 20, 2022
  • 483 - 2019-11-15November 15, 2019
  • 483 - 2018-04-20April 20, 2018

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Nephron Sterile Compounding Center LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.